1. Home
  2. CTMX vs SGA Comparison

CTMX vs SGA Comparison

Compare CTMX & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • SGA
  • Stock Information
  • Founded
  • CTMX 2008
  • SGA 1986
  • Country
  • CTMX United States
  • SGA United States
  • Employees
  • CTMX N/A
  • SGA N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • SGA Broadcasting
  • Sector
  • CTMX Health Care
  • SGA Consumer Discretionary
  • Exchange
  • CTMX Nasdaq
  • SGA Nasdaq
  • Market Cap
  • CTMX 89.1M
  • SGA 89.2M
  • IPO Year
  • CTMX 2015
  • SGA 1992
  • Fundamental
  • Price
  • CTMX $0.89
  • SGA $13.19
  • Analyst Decision
  • CTMX Buy
  • SGA
  • Analyst Count
  • CTMX 6
  • SGA 0
  • Target Price
  • CTMX $5.77
  • SGA N/A
  • AVG Volume (30 Days)
  • CTMX 1.1M
  • SGA 17.0K
  • Earning Date
  • CTMX 11-07-2024
  • SGA 11-07-2024
  • Dividend Yield
  • CTMX N/A
  • SGA 7.58%
  • EPS Growth
  • CTMX N/A
  • SGA N/A
  • EPS
  • CTMX 0.16
  • SGA 0.75
  • Revenue
  • CTMX $126,617,000.00
  • SGA $110,669,000.00
  • Revenue This Year
  • CTMX $11.79
  • SGA $0.49
  • Revenue Next Year
  • CTMX N/A
  • SGA $0.18
  • P/E Ratio
  • CTMX $5.51
  • SGA $17.58
  • Revenue Growth
  • CTMX 33.66
  • SGA N/A
  • 52 Week Low
  • CTMX $0.83
  • SGA $11.71
  • 52 Week High
  • CTMX $5.85
  • SGA $27.00
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 35.66
  • SGA 49.27
  • Support Level
  • CTMX $0.84
  • SGA $11.71
  • Resistance Level
  • CTMX $1.08
  • SGA $14.09
  • Average True Range (ATR)
  • CTMX 0.07
  • SGA 0.45
  • MACD
  • CTMX -0.01
  • SGA 0.00
  • Stochastic Oscillator
  • CTMX 17.43
  • SGA 62.18

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About SGA Saga Communications Inc. (FL)

Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets and It derives a majority of its revenue from the sale of advertising for broadcast on its stations.

Share on Social Networks: